Literature DB >> 10954238

Long-term outcome of epilepsy.

M Sillanpää1.   

Abstract

Few prospective, population-based, long-term follow-up studies exist on people with epilepsy. Still fewer reports cover social outcome. Overall mortality is two to three times higher than expected. The contribution of epilepsy is variable. Importantly, the type of epilepsy syndrome and gender must be considered in the estimation of mortality rates in epilepsy. Sudden unexpected death and its mechanisms also need further consideration. Approximately. two thirds of surviving patients will be in terminal remission twenty years after onset of epilepsy and half of them are seizure-free without medication. The best independent predictors of remission are absence of organic brain damage, low intensity seizure propensity and good early effect of drug therapy. The long-term outcome is often predictable by observation of the early outcome of seizures. One third of children with epilepsy are mentally retarded. Poor social outcome is related to associated neurological disabilities, drug resistant seizures and polytherapy. However, even patients with uncomplicated epilepsy, idiopathic etiology and terminal remission without medication do less favourably than their matched controls in basic and vocational education, and reproductive activity. The employability of this subgroup, however, does not differ significantly from that of controls, compared with approximately 60% of all people with epilepsy. Further research is needed particularly to enable a better determination of predictors of long-term outcome, recurrence of seizures after drug withdrawal and the role of drug therapy in long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954238

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  8 in total

Review 1.  Health-related quality of life in youth with epilepsy: theoretical model for clinicians and researchers. Part I: the role of epilepsy and co-morbidity.

Authors:  Lucyna M Lach; Gabriel M Ronen; Peter L Rosenbaum; Charles Cunningham; Michael H Boyle; Shauna Bowman; David L Streiner
Journal:  Qual Life Res       Date:  2006-09-13       Impact factor: 4.147

2.  Comparison between Initial and Recent Surgical Outcome of 15-Year Series of Surgically Remediable Epilepsy.

Authors:  Myoung-Hee Lee; Eun-Ik Son
Journal:  J Korean Neurosurg Soc       Date:  2010-09-30

3.  Comparative role of neuropsychological testing in the presurgical evaluation of children with medically intractable epilepsies.

Authors:  Cecília Souza-Oliveira; Sara Escorsi-Rosset; Marino Muxfeldt Bianchin; Vera Cristina Terra; Lauro Wichert-Ana; Hélio Rubens Machado; Américo Ceiki Sakamoto
Journal:  Childs Nerv Syst       Date:  2009-02-28       Impact factor: 1.475

Review 4.  New developments in the management of partial-onset epilepsy: role of brivaracetam.

Authors:  Giangennaro Coppola; Giulia Iapadre; Francesca Felicia Operto; Alberto Verrotti
Journal:  Drug Des Devel Ther       Date:  2017-03-06       Impact factor: 4.162

5.  Investigating the relationship of positive family history pattern and the incidence and prognosis of idiopathic epilepsy in epilepsy patients.

Authors:  Masoud Ghiasian; Sajjad Daneshyar; Elham Khanlarzadeh; Mohammadreza Bolouri Novin
Journal:  Caspian J Intern Med       Date:  2020

6.  Interictal epileptogenic zone localization in patients with focal epilepsy using electric source imaging and directed functional connectivity from low-density EEG.

Authors:  Ana Coito; Silke Biethahn; Janina Tepperberg; Margherita Carboni; Ulrich Roelcke; Margitta Seeck; Pieter van Mierlo; Markus Gschwind; Serge Vulliemoz
Journal:  Epilepsia Open       Date:  2019-04-14

7.  Practice trends and the outcome of neuromodulation therapies in epilepsy: A single-center study.

Authors:  Rabia Jamy; Manmeet Kaur; Diana Pizarro; Emilia Toth; Sandipan Pati
Journal:  Epilepsia Open       Date:  2019-06-11

8.  Outcome at age 7 of epilepsy presenting in the first 2 years of life. A population-based study.

Authors:  Tommy Stödberg; Torbjörn Tomson; Britt-Marie Anderlid; Tomas Andersson; Olivia Henry; Per Åmark; Anna Wedell
Journal:  Epilepsia       Date:  2022-06-25       Impact factor: 6.740

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.